138 related articles for article (PubMed ID: 15966179)
1. Collagen IV is a predictor for clinical course in patients with malignant obstructive jaundice.
Mizuguchi Y; Yoshida H; Yokomuro S; Arima Y; Mamada Y; Taniai N; Akimaru K; Tajiri T
Hepatogastroenterology; 2005; 52(63):672-7. PubMed ID: 15966179
[TBL] [Abstract][Full Text] [Related]
2. Effect of jaundice and its resolution on wound re-epithelization, skin collagen synthesis, and serum collagen propeptide levels in patients with neoplastic pancreaticobiliary obstruction.
Koivukangas V; Oikarinen A; Risteli J; Haukipuro K
J Surg Res; 2005 Apr; 124(2):237-43. PubMed ID: 15820253
[TBL] [Abstract][Full Text] [Related]
3. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
[TBL] [Abstract][Full Text] [Related]
4. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting.
Brountzos EN; Ptochis N; Panagiotou I; Malagari K; Tzavara C; Kelekis D
Cardiovasc Intervent Radiol; 2007; 30(1):66-73. PubMed ID: 17031733
[TBL] [Abstract][Full Text] [Related]
5. Serum endothelin-1 and hepatocyte growth factor levels in patients with obstructive jaundice.
Higaki I; Yamazaki O; Matsuyama M; Horii K; Kawai S; Tsukamoto T; Tanaka H; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 1999; 46(27):1599-602. PubMed ID: 10430302
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
Sasaki N; Ueno T; Morita Y; Nagata E; Sata M
Hepatogastroenterology; 2006; 53(71):678-81. PubMed ID: 17086867
[TBL] [Abstract][Full Text] [Related]
7. [Epirubicin in the treatment of malignant obstructive jaundice].
Chen Y; Yan ZP; Wang JH; Wang XL; Cheng JM; Gong GQ; Liu QX; Qian S; Liu R; Luo JJ
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):397-9. PubMed ID: 17045011
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice].
Bai AG; Zheng CS; Zhou GF; Liang HM; Feng GS
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):456-8. PubMed ID: 20819490
[TBL] [Abstract][Full Text] [Related]
10. Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study.
Kubo K; Kawakami H; Kuwatani M; Nishida M; Kawakubo K; Kawahata S; Taya Y; Kubota Y; Amano T; Shirato H; Sakamoto N
BMC Gastroenterol; 2016 Jul; 16(1):65. PubMed ID: 27391646
[TBL] [Abstract][Full Text] [Related]
11. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.
Beyazit Y; Kekilli M; Ibis M; Kurt M; Sayilir A; Onal IK; Purnak T; Oztas E; Tas A; Yesil Y; Arhan M
Hepatogastroenterology; 2012; 59(117):1469-73. PubMed ID: 22683963
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of functional liver reserve in patients with obstructive jaundice undergoing hepatectomy.
Higuchi R; Otsubo T; Takasaki K
Hepatogastroenterology; 2005; 52(62):537-40. PubMed ID: 15816473
[TBL] [Abstract][Full Text] [Related]
13. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
[TBL] [Abstract][Full Text] [Related]
14. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
Mann DV; Edwards R; Ho S; Lau WY; Glazer G
Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of serum neopterin in obstructive jaundice secondary to malignant lesions treated by percutaneous transhepatic biliary drainage.
Yilmaz B; Parildar Z; Bozkaya H; Barutcuoglu B; Cinar C; Basol G; Parildar M; Ozmen D
J Vasc Interv Radiol; 2013 Jun; 24(6):865-72. PubMed ID: 23707094
[TBL] [Abstract][Full Text] [Related]
16. Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage.
Shimahara Y; Yamamoto N; Uyama N; Okuyama H; Momoi H; Kamikawa T; Terajima H; Iimuro Y; Yamamoto Y; Ikai I; Kushihata F; Kiyochi H; Kobayashi N; Yamaoka Y
World J Surg; 2002 Apr; 26(4):451-6. PubMed ID: 11910479
[TBL] [Abstract][Full Text] [Related]
17. Preoperative hyaluronic acid measurement to assess the hepatic functional reserve.
Suehiro T; Matsumata T; Shikada Y; Shimada M; Shirabe K; Sugimachi K
Hepatogastroenterology; 2004; 51(60):1776-9. PubMed ID: 15532824
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
19. Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer.
Makino T; Fujitani K; Tsujinaka T; Hirao M; Kashiwazaki M; Nakamori S; Ikenaga M; Mishima H; Masuda N; Sawamura T
Hepatogastroenterology; 2008; 55(81):54-7. PubMed ID: 18507078
[TBL] [Abstract][Full Text] [Related]
20. Cholecystostomy and PTBD in the treatment of obstructive jaundice (a comparative study).
Nicoli N; Benati G; Mainente M; Tenchini P; Pedron G; Mangiante G; Marchiori L
Chir Ital; 1984 Aug; 36(4):582-8. PubMed ID: 6525711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
